X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE DR. REDDYS LAB TTK HEALTHCARE/
DR. REDDYS LAB
 
P/E (TTM) x 17.1 27.7 61.6% View Chart
P/BV x 5.6 3.4 162.6% View Chart
Dividend Yield % 0.5 0.8 67.8%  

Financials

 TTK HEALTHCARE   DR. REDDYS LAB
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
DR. REDDYS LAB
Mar-18
TTK HEALTHCARE/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs6632,788 23.8%   
Low Rs3991,902 21.0%   
Sales per share (Unadj.) Rs535.6860.8 62.2%  
Earnings per share (Unadj.) Rs15.957.1 27.9%  
Cash flow per share (Unadj.) Rs20.0122.0 16.4%  
Dividends per share (Unadj.) Rs4.0020.00 20.0%  
Dividend yield (eoy) %0.80.9 88.3%  
Book value per share (Unadj.) Rs137.6757.7 18.2%  
Shares outstanding (eoy) m7.77165.91 4.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.02.7 36.4%   
Avg P/E ratio x33.341.1 81.1%  
P/CF ratio (eoy) x26.519.2 138.0%  
Price / Book Value ratio x3.93.1 124.7%  
Dividend payout %25.135.0 71.6%   
Avg Mkt Cap Rs m4,127389,034 1.1%   
No. of employees `0001.723.5 7.3%   
Total wages/salary Rs m60732,149 1.9%   
Avg. sales/employee Rs Th2,436.76,070.8 40.1%   
Avg. wages/employee Rs Th355.21,366.6 26.0%   
Avg. net profit/employee Rs Th72.5402.5 18.0%   
INCOME DATA
Net Sales Rs m4,162142,810 2.9%  
Other income Rs m611,552 3.9%   
Total revenues Rs m4,223144,362 2.9%   
Gross profit Rs m19723,512 0.8%  
Depreciation Rs m3210,772 0.3%   
Interest Rs m30788 3.8%   
Profit before tax Rs m19713,504 1.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m0344 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m734,380 1.7%   
Profit after tax Rs m1249,468 1.3%  
Gross profit margin %4.716.5 28.8%  
Effective tax rate %37.032.4 114.1%   
Net profit margin %3.06.6 44.9%  
BALANCE SHEET DATA
Current assets Rs m1,629104,984 1.6%   
Current liabilities Rs m1,05868,938 1.5%   
Net working cap to sales %13.725.2 54.3%  
Current ratio x1.51.5 101.1%  
Inventory Days Days3074 40.0%  
Debtors Days Days34104 32.4%  
Net fixed assets Rs m556104,385 0.5%   
Share capital Rs m78830 9.4%   
"Free" reserves Rs m878124,886 0.7%   
Net worth Rs m1,069125,716 0.9%   
Long term debt Rs m15925,089 0.6%   
Total assets Rs m2,399225,443 1.1%  
Interest coverage x7.618.1 41.8%   
Debt to equity ratio x0.10.2 74.4%  
Sales to assets ratio x1.70.6 273.8%   
Return on assets %6.44.5 140.9%  
Return on equity %11.67.5 153.9%  
Return on capital %18.59.7 190.1%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m3372,623 0.0%   
Fx outflow Rs m6318,916 0.3%   
Net fx Rs m-3053,707 -0.1%   
CASH FLOW
From Operations Rs m12718,030 0.7%  
From Investments Rs m-146-14,883 1.0%  
From Financial Activity Rs m22-4,440 -0.5%  
Net Cashflow Rs m3-1,236 -0.2%  

Share Holding

Indian Promoters % 65.4 25.5 256.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 5.4 68.5%  
FIIs % 5.2 35.3 14.7%  
ADR/GDR % 0.0 18.5 -  
Free float % 25.8 15.3 168.6%  
Shareholders   12,723 75,885 16.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   GSK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

From Urjit Patel to Shaktikanta Das; What Lies Ahead?(Podcast)

The week gone by saw Sensex plunge from 700 points to rise by over 600 points. With a volatile and eventful week, it was a challenge keeping up with the news every day.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Players in an Oligopoly Should Have Financials Like This(Chart Of The Day)

Dec 7, 2018

This stock has corrected 30% from peak and looks attractive at these valuations.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Dec 14, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - PLETHICO PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS